171 related articles for article (PubMed ID: 24431404)
1. Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
Janakiram NB; Mohammed A; Brewer M; Bryant T; Biddick L; Lightfoot S; Pathuri G; Gali H; Rao CV
Cancer Prev Res (Phila); 2014 Mar; 7(3):300-9. PubMed ID: 24431404
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.
Ravillah D; Mohammed A; Qian L; Brewer M; Zhang Y; Biddick L; Steele VE; Rao CV
J Pharmacol Exp Ther; 2014 Jan; 348(1):59-68. PubMed ID: 24218540
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.
Mohammed A; Janakiram NB; Li Q; Choi CI; Zhang Y; Steele VE; Rao CV
Cancer Prev Res (Phila); 2011 Dec; 4(12):2015-26. PubMed ID: 21885812
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effect of ERβ-Selective agonist on intestinal tumorigenesis in Apc(Min/+) mice.
Giroux V; Bernatchez G; Carrier JC
Mol Carcinog; 2011 May; 50(5):359-69. PubMed ID: 21480389
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.
Janakiram NB; Mohammed A; Qian L; Choi CI; Steele VE; Rao CV
Neoplasia; 2012 Feb; 14(2):159-68. PubMed ID: 22431924
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.
Janakiram NB; Mohammed A; Zhang Y; Brewer M; Bryant T; Lightfoot S; Steele VE; Rao CV
Cancer Prev Res (Phila); 2013 Dec; 6(12):1251-61. PubMed ID: 24080207
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein.
Janakiram NB; Mohammed A; Bryant T; Brewer M; Biddick L; Lightfoot S; Lang ML; Rao CV
Mol Carcinog; 2015 Oct; 54(10):986-98. PubMed ID: 24797894
[TBL] [Abstract][Full Text] [Related]
9. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation.
Nalbandian G; Paharkova-Vatchkova V; Mao A; Nale S; Kovats S
J Immunol; 2005 Aug; 175(4):2666-75. PubMed ID: 16081843
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.
Shibata MA; Morimoto J; Shibata E; Kurose H; Akamatsu K; Li ZL; Kusakabe M; Ohmichi M; Otsuki Y
BMC Cancer; 2010 Oct; 10():566. PubMed ID: 20958960
[TBL] [Abstract][Full Text] [Related]
11. Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.
Mohammed A; Janakiram NB; Brewer M; Vedala K; Steele VE; Rao CV
Neoplasia; 2013 May; 15(5):481-90. PubMed ID: 23633920
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 regulates spontaneous intestinal tumorigenesis by up-regulating IL-6 and GM-CSF.
Shi YJ; Zhao QQ; Liu XS; Dong SH; E JF; Li X; Liu C; Wang H
J Cell Mol Med; 2020 Jan; 24(1):385-397. PubMed ID: 31650683
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for altered reproductive function in female rats following neonatal administration of raloxifene.
Tena-Sempere M; Barreiro ML; Aguilar E; Pinilla L
Eur J Endocrinol; 2004 Mar; 150(3):397-403. PubMed ID: 15012627
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
[TBL] [Abstract][Full Text] [Related]
15. Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action.
Sporn MB; Dowsett SA; Mershon J; Bryant HU
Clin Ther; 2004 Jun; 26(6):830-40. PubMed ID: 15262454
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity.
Benbrook DM; Guruswamy S; Wang Y; Sun Z; Mohammed A; Zhang Y; Li Q; Rao CV
Cancer Prev Res (Phila); 2013 Sep; 6(9):908-16. PubMed ID: 23852423
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques.
Bethea CL; Mirkes SJ; Su A; Michelson D
Psychoneuroendocrinology; 2002 May; 27(4):431-45. PubMed ID: 11911997
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice.
Lei DL; Long JM; Hengemihle J; O'Neill J; Manaye KF; Ingram DK; Mouton PR
Neuroscience; 2003; 121(3):659-66. PubMed ID: 14568026
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene suppresses experimental autoimmune encephalomyelitis and NF-κB-dependent CCL20 expression in reactive astrocytes.
Li R; Xu W; Chen Y; Qiu W; Shu Y; Wu A; Dai Y; Bao J; Lu Z; Hu X
PLoS One; 2014; 9(4):e94320. PubMed ID: 24722370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
